AXNX insider filings
Axonics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-11-15. Screen AXNX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for AXNX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Axonics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-11-15 | 4 | Woock John — EVP, Chief Mktg/Strtgy Officer | Disposition to issuer (D): 77,403 @ $71 · Disposition to issuer (D): 13,125 (derivative) @ $0 · Disposition to issuer (D): 15,555 (derivative) @ $56.81 · Disposition to issuer (D): 3,581 (derivative) @ $45.18 | EDGAR |
| 2024-11-15 | 4 | snyderman nancy lynn MD — Director | Disposition to issuer (D): 14,944 @ $71 · Disposition to issuer (D): 4,167 (derivative) @ $36.90 · Disposition to issuer (D): 10,000 (derivative) @ $49.96 | EDGAR |
| 2024-11-15 | 4 | Sama Rinda — Chief Operating Officer | Disposition to issuer (D): 83,854 @ $71 · Disposition to issuer (D): 608 @ $71 · Disposition to issuer (D): 13,125 (derivative) @ $0 · Disposition to issuer (D): 11,019 (derivative) @ $56.81 · Disposition to issuer (D): 9,962 (derivative) @ $45.18 · Disposition to issuer (D): 6,294 (derivative) @ $69.37 | EDGAR |
| 2024-11-15 | 4 | Noblett Karen — Chief Medical Officer | Disposition to issuer (D): 34,428 @ $71 · Disposition to issuer (D): 7,500 (derivative) @ $0 · Disposition to issuer (D): 2,963 (derivative) @ $56.81 · Disposition to issuer (D): 6,348 (derivative) @ $45.18 · Disposition to issuer (D): 11,998 (derivative) @ $69.37 | EDGAR |
| 2024-11-15 | 4 | Lopez Esteban — Director | Disposition to issuer (D): 6,600 @ $71 · Disposition to issuer (D): 10,000 (derivative) @ $11.30 | EDGAR |
| 2024-11-15 | 4 | Keese Kari Leigh — Chief Financial Officer | Disposition to issuer (D): 40,362 @ $71 · Disposition to issuer (D): 3,125 (derivative) @ $0 | EDGAR |
| 2024-11-15 | 4 | Demski David M — Director | Disposition to issuer (D): 9,542 @ $71 · Disposition to issuer (D): 10,000 (derivative) @ $19.30 | EDGAR |
| 2024-11-15 | 4 | McNamara Robert — Director | Disposition to issuer (D): 14,861 @ $71 · Disposition to issuer (D): 10,000 (derivative) @ $36.90 · Disposition to issuer (D): 3,333 (derivative) @ $33.85 · Disposition to issuer (D): 5,000 (derivative) @ $56.20 | EDGAR |
| 2024-11-15 | 4 | Kiernan Jane E — Director | Disposition to issuer (D): 19,861 @ $71 | EDGAR |
| 2024-11-15 | 4 | Ford Alfred J Jr — Chief Commercial Officer | Disposition to issuer (D): 43,450 @ $71 · Disposition to issuer (D): 11,250 (derivative) @ $0 · Disposition to issuer (D): 4,655 (derivative) @ $45.18 | EDGAR |
| 2024-11-15 | 4 | COHEN RAYMOND W — Chief Executive Officer, Director | Disposition to issuer (D): 292,731 @ $71 · Disposition to issuer (D): 31,125 (derivative) @ $0 · Disposition to issuer (D): 196,451 (derivative) @ $56.81 · Disposition to issuer (D): 106,776 (derivative) @ $69.37 | EDGAR |
| 2024-11-15 | 4 | CARREL MICHAEL H — Director | Disposition to issuer (D): 17,861 @ $71 · Disposition to issuer (D): 5,000 (derivative) @ $36.90 · Disposition to issuer (D): 10,000 (derivative) @ $50.15 | EDGAR |
| 2024-11-12 | 4 | snyderman nancy lynn MD — Director | Gift (G): 5,000 @ $0 | EDGAR |
| 2024-10-03 | 4 | Keese Kari Leigh — Chief Financial Officer | Sale (S): 364 @ $69.40 · Sale (S): 2,597 @ $69.41 | EDGAR |
| 2024-07-25 | 4 | COHEN RAYMOND W — Chief Executive Officer, Director | Option exercise (M): 25,771 @ $14.19 · Option exercise (M): 78,125 @ $25.82 · Option exercise (M): 78,125 (derivative) @ $0 · Option exercise (M): 25,771 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Noblett Karen — Chief Medical Officer | Option exercise (M): 27,500 @ $0 · Sale (S): 11,288 @ $67.74 · Option exercise (M): 6,500 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Sama Rinda — Chief Operating Officer | Option exercise (M): 28,000 @ $0 · Option exercise (M): 10,500 (derivative) @ $0 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Woock John — EVP, Chief Mktg/Strtgy Officer | Option exercise (M): 28,000 @ $0 · Sale (S): 15,899 @ $67.74 · Option exercise (M): 10,500 (derivative) @ $0 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Keese Kari Leigh — Chief Financial Officer | Option exercise (M): 6,167 @ $0 · Sale (S): 3,489 @ $67.74 · Option exercise (M): 2,000 (derivative) @ $0 · Option exercise (M): 4,167 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Ford Alfred J Jr — Chief Commercial Officer | Option exercise (M): 25,500 @ $0 · Sale (S): 16,615 @ $67.74 · Option exercise (M): 10,500 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | COHEN RAYMOND W — Chief Executive Officer, Director | Option exercise (M): 63,400 @ $0 · Sale (S): 35,161 @ $67.74 · Option exercise (M): 21,900 (derivative) @ $0 · Option exercise (M): 41,500 (derivative) @ $0 | EDGAR |
| 2024-01-10 | 4 | Noblett Karen — Chief Medical Officer | Sale (S): 15,999 @ $69.00 | EDGAR |
| 2023-12-28 | 4 | Noblett Karen — Chief Medical Officer | Sale (S): 949 @ $63 · Sale (S): 7,051 @ $63.28 | EDGAR |
| 2023-10-03 | 4 | Dearen Danny L. — President & CFO | Option exercise (M): 11,250 @ $0 · Sale (S): 7,675 @ $56.87 · Option exercise (M): 11,250 (derivative) @ $0 | EDGAR |
| 2023-10-03 | 4/A | Dearen Danny L. — President & CFO | Option exercise (M): 36,919 @ $0 · Sale (S): 17,737 @ $48.21 · Sale (S): 947 @ $49.03 | EDGAR |
| 2023-08-17 | 4 | Ford Alfred J Jr — Chief Commercial Officer | Sale (S): 14,769 @ $62.34 | EDGAR |
| 2023-08-08 | 4 | CARREL MICHAEL H — Director | Gift (G): 500 @ $0 | EDGAR |
| 2023-08-01 | 4 | Ford Alfred J Jr — Chief Commercial Officer | Sale (S): 1,500 @ $62.01 | EDGAR |
| 2023-06-28 | 4 | Lopez Esteban — Director | Grant/award (A): 3,000 @ $0 | EDGAR |
| 2023-06-28 | 4 | snyderman nancy lynn MD — Director | Grant/award (A): 3,000 @ $0 | EDGAR |
| 2023-06-28 | 4 | Demski David M — Director | Grant/award (A): 3,000 @ $0 | EDGAR |
| 2023-06-28 | 4 | McNamara Robert — Director | Grant/award (A): 3,000 @ $0 | EDGAR |
| 2023-06-28 | 4 | Kiernan Jane E — Director | Grant/award (A): 3,000 @ $0 | EDGAR |
| 2023-06-28 | 4 | CARREL MICHAEL H — Director | Grant/award (A): 3,000 @ $0 | EDGAR |
| 2023-05-31 | 4 | Dearen Danny L. — President & CFO | Sale (S): 7,699 @ $49.44 · Sale (S): 300 @ $50.14 | EDGAR |
| 2023-04-25 | 4 | Dearen Danny L. — President & CFO | Option exercise (M): 13,208 @ $14.19 · Sale (S): 10,363 @ $59.93 · Sale (S): 9,637 @ $60.50 · Option exercise (M): 13,208 (derivative) @ $0 | EDGAR |
| 2023-04-24 | 4 | Dearen Danny L. — President & CFO | Option exercise (M): 2,001 @ $14.19 · Sale (S): 2,001 @ $60.01 · Option exercise (M): 2,001 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | Dearen Danny L. — President & CFO | Option exercise (M): 6,633 @ $14.19 · Option exercise (M): 5,468 @ $25.82 · Option exercise (M): 2,899 @ $1.63 · Sale (S): 7,198 @ $54.83 · Sale (S): 7,802 @ $55.68 · Option exercise (M): 6,633 (derivative) @ $0 · +2 more | EDGAR |
| 2023-02-23 | 4 | Sama Rinda — Chief Operating Officer | Sale (S): 16,229 @ $56.18 · Sale (S): 3,700 @ $56.69 · Sale (S): 3,392 @ $56.53 | EDGAR |
| 2023-02-02 | 4 | Sama Rinda — Chief Operating Officer | Grant/award (A): 8,750 @ $0 · Option exercise (M): 30,875 @ $0 · Sale (S): 7,791 @ $61.17 · Sale (S): 5,634 @ $61.12 · Sale (S): 741 @ $60.43 · Sale (S): 4,334 @ $61.02 · +4 more | EDGAR |
| 2023-02-02 | 4 | Dearen Danny L. — President & CFO | Grant/award (A): 5,000 @ $0 · Option exercise (M): 25,250 @ $0 · Sale (S): 7,791 @ $61.17 · Sale (S): 2,720 @ $61.12 · Sale (S): 474 @ $60.43 · Sale (S): 2,772 @ $61.02 · +4 more | EDGAR |
| 2023-02-02 | 4 | Noblett Karen — Chief Medical Officer | Grant/award (A): 5,000 @ $0 · Option exercise (M): 10,250 @ $0 · Sale (S): 2,167 @ $61.17 · Sale (S): 1,536 @ $61.12 · Sale (S): 136 @ $60.43 · Sale (S): 795 @ $61.02 · +4 more | EDGAR |
| 2023-02-02 | 4 | Woock John — EVP, Chief Mktg/Strtgy Officer | Grant/award (A): 8,750 @ $0 · Option exercise (M): 22,125 @ $0 · Sale (S): 3,389 @ $61.17 · Sale (S): 4,181 @ $61.12 · Sale (S): 581 @ $60.43 · Sale (S): 3,398 @ $61.02 · +4 more | EDGAR |
| 2023-02-02 | 4 | Ford Alfred J Jr — Chief Commercial Officer | Grant/award (A): 7,500 @ $0 · Option exercise (M): 16,500 @ $0 · Sale (S): 4,235 @ $61.17 · Sale (S): 1,999 @ $61.12 · Sale (S): 541 @ $60.43 · Sale (S): 3,164 @ $61.02 · +4 more | EDGAR |
| 2023-02-02 | 4 | COHEN RAYMOND W — Chief Executive Officer, Director | Grant/award (A): 20,750 @ $0 · Option exercise (M): 61,968 @ $0 · Sale (S): 13,872 @ $61.17 · Sale (S): 9,032 @ $61.12 · Sale (S): 1,185 @ $60.43 · Sale (S): 6,932 @ $61.02 · +4 more | EDGAR |
| 2023-01-19 | 4 | Woock John — EVP, Chief Mktg/Strtgy Officer | Option exercise (M): 2,793 @ $1.32 · Sale (S): 2,793 @ $67.62 · Option exercise (M): 378 @ $1.42 · Sale (S): 378 @ $67.51 · Option exercise (M): 15,000 @ $14.19 · Sale (S): 15,000 @ $67.29 · +6 more | EDGAR |
| 2023-01-18 | 4 | Ford Alfred J Jr — Chief Commercial Officer | Option exercise (M): 8,509 @ $1.42 · Option exercise (M): 1,899 @ $1.63 · Option exercise (M): 9,310 @ $25.82 · Option exercise (M): 16,297 @ $14.19 · Sale (S): 15,292 @ $65.90 · Sale (S): 17,108 @ $66.69 · +5 more | EDGAR |
| 2023-01-18 | 4 | COHEN RAYMOND W — Chief Executive Officer, Director | Sale (S): 18,684 @ $65.54 · Sale (S): 22,052 @ $66.27 | EDGAR |
| 2022-12-15 | 4 | Lopez Esteban — Director | Sale (S): 2,000 @ $67.42 | EDGAR |
| 2022-09-20 | 4 | Noblett Karen — Chief Medical Officer | Option exercise (M): 18,519 @ $14.19 · Option exercise (M): 13,964 @ $25.82 · Sale (S): 32,483 @ $78.16 · Option exercise (M): 18,519 (derivative) @ $0 · Option exercise (M): 13,964 (derivative) @ $0 | EDGAR |
Recent 8-K events — Axonics, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-11-15 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-08-01 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-04-04 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-03-25 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-08 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AXNX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs